CS Diagnostics Corp. (CSDX)
OTC Markets OTCPK
Fundamentals
Valuation and ratings
CS Diagnostics Corp. trades at USD0.07. We do not hold enough of the inputs to run a discounted cash flow on this company, so we publish no fair value for it rather than a number we would not defend.
About CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming.
The full research page for CSDX, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.